Development of doxorubicin-induced chronic cardiotoxicity in the B6C3F(1) mouse model
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Desai, Varsha G. | - |
dc.contributor.author | Herman, Eugene H. | - |
dc.contributor.author | Moland, Carrie L. | - |
dc.contributor.author | Branham, William S. | - |
dc.contributor.author | Lewis, Sherry M. | - |
dc.contributor.author | Davis, Kelly J. | - |
dc.contributor.author | George, Nysia I. | - |
dc.contributor.author | Lee, Taewon | - |
dc.contributor.author | Kerr, Susan | - |
dc.contributor.author | Fuscoe, James C. | - |
dc.date.accessioned | 2021-09-06T05:28:48Z | - |
dc.date.available | 2021-09-06T05:28:48Z | - |
dc.date.created | 2021-06-14 | - |
dc.date.issued | 2013-01-01 | - |
dc.identifier.issn | 0041-008X | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/104232 | - |
dc.description.abstract | Serum levels of cardiac troponins serve as biomarkers of myocardial injury. However, troponins are released into the serum only after damage to cardiac tissue has occurred. Here, we report development of a mouse model of doxorubicin (DOX)-induced chronic cardiotoxicity to aid in the identification of predictive biomarkers of early events of cardiac tissue injury. Male B6C3F(1) mice were administered intravenous DOX at 3 mg/kg body weight, or an equivalent volume of saline, once a week for 4, 6, 8, 10, 12, and 14 weeks, resulting in cumulative DOX doses of 12, 18, 24, 30, 36, and 42 mg/kg, respectively. Mice were sacrificed a week following the last dose. A significant reduction in body weight gain was observed in mice following exposure to a weekly DOX dose for 1 week and longer compared to saline-treated controls. DOX treatment also resulted in declines in red blood cell count, hemoglobin level, and hematocrit compared to saline-treated controls after the 2nd weekly dose until the 8th and 9th doses, followed by a modest recovery. All DOX-treated mice had significant elevations in cardiac troponin T concentrations in plasma compared to saline-treated controls, indicating cardiac tissue injury. Also, a dose-related increase in the severity of cardiac lesions was seen in mice exposed to 24 mg/kg DOX and higher cumulative doses. Mice treated with cumulative DOX doses of 30 mg/kg and higher showed a significant decline in heart rate, suggesting drug-induced cardiac dysfunction. Altogether, these findings demonstrate the development of DOX-induced chronic cardiotoxicity in B6C3F(1) mice. Published by Elsevier Inc. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | ACADEMIC PRESS INC ELSEVIER SCIENCE | - |
dc.subject | CARDIAC TROPONIN-T | - |
dc.subject | MITOCHONDRIA-RELATED GENES | - |
dc.subject | BREAST-CANCER PATIENTS | - |
dc.subject | MYOCARDIAL DAMAGE | - |
dc.subject | ANTHRACYCLINE CARDIOMYOPATHY | - |
dc.subject | ADRIAMYCIN CARDIOTOXICITY | - |
dc.subject | HEPATOCELLULAR-CARCINOMA | - |
dc.subject | EXPRESSION PROFILE | - |
dc.subject | SERUM-LEVELS | - |
dc.subject | BEAGLE DOGS | - |
dc.title | Development of doxorubicin-induced chronic cardiotoxicity in the B6C3F(1) mouse model | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Lee, Taewon | - |
dc.identifier.doi | 10.1016/j.taap.2012.10.025 | - |
dc.identifier.scopusid | 2-s2.0-84870218977 | - |
dc.identifier.wosid | 000313474200013 | - |
dc.identifier.bibliographicCitation | TOXICOLOGY AND APPLIED PHARMACOLOGY, v.266, no.1, pp.109 - 121 | - |
dc.relation.isPartOf | TOXICOLOGY AND APPLIED PHARMACOLOGY | - |
dc.citation.title | TOXICOLOGY AND APPLIED PHARMACOLOGY | - |
dc.citation.volume | 266 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 109 | - |
dc.citation.endPage | 121 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalResearchArea | Toxicology | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Toxicology | - |
dc.subject.keywordPlus | CARDIAC TROPONIN-T | - |
dc.subject.keywordPlus | MITOCHONDRIA-RELATED GENES | - |
dc.subject.keywordPlus | BREAST-CANCER PATIENTS | - |
dc.subject.keywordPlus | MYOCARDIAL DAMAGE | - |
dc.subject.keywordPlus | ANTHRACYCLINE CARDIOMYOPATHY | - |
dc.subject.keywordPlus | ADRIAMYCIN CARDIOTOXICITY | - |
dc.subject.keywordPlus | HEPATOCELLULAR-CARCINOMA | - |
dc.subject.keywordPlus | EXPRESSION PROFILE | - |
dc.subject.keywordPlus | SERUM-LEVELS | - |
dc.subject.keywordPlus | BEAGLE DOGS | - |
dc.subject.keywordAuthor | Doxorubicin | - |
dc.subject.keywordAuthor | Cardiac troponin T | - |
dc.subject.keywordAuthor | Cardiac lesions | - |
dc.subject.keywordAuthor | Hematotoxicity | - |
dc.subject.keywordAuthor | Male B6C3F(1) mice | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.